This trial is evaluating whether ACT for Life will improve 2 primary outcomes and 4 other outcomes in patients with Suicide. Measurement will happen over the course of Baseline, Pre-discharge (within 4 days of hospital discharge), and 1-, 3-, 6-, and 12-months post-discharge from psychiatric inpatient unit.
This trial requires 278 total participants across 2 different treatment groups
This trial involves 2 different treatments. ACT For Life is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
Each year, an estimated 13.2% of US adults die by suicide. A significant proportion will be elderly and male and will be uninsured. The American suicide rate would be slightly lower if the definition of suicide included attempting suicide. Thus, the suicide rate should not be used to measure the current US mood or suicide risk.
Suicide is most commonly committed by men in middle age, young black men, and men with no history of mental illness. Factors that increase the risk of suicide include current drug use, prior history of mental illness, prior history of suicide attempts, family history of mental illness, lack of social supports, financial difficulties, lack of employment, low grade of education, low grade in school, and low family social and economic status. A higher rate of suicide is observed in people with depressive disorders. The study also demonstrated that a significant proportion of suicide victims were current smokers.
Signatures for suicide are a combination of a depressed mood and a plan of bringing the behavior to a successful conclusion. In light of the lack of specificity of signs or symptoms, the identification of signs are of limited value in identifying suicidal subjects.
Suicide may be defined as a behavioral action that results in the loss of life in a person who is psychologically capable of doing otherwise in a healthy state. Suicide rate continues to rise in both developed and developing countries and there continues to be a significant financial burden to society which can be reduced substantially through prevention and treatment. In 2008, suicide resulted in about 0.7827 million deaths. According to WHO, the world's 25th highest cause of death was suicide in 2008 with 1.62 million cases of fatal attempted suicide and 998 thousand suicides. Gender does differ in the prevalence and mortality of suicide. Males can die of suicide at about 15 years and the females at about 25 years.
Findings from a recent study shows the need to understand suicide in the context of psychiatric disorders, particularly considering that suicide is not just about death. Psychiatric interventions may help people with mood disorders to live healthy and productive lives, but the challenge is ensuring that suicide is not treated as just a symptom of the disorder but it is also a relevant, understandable and personal issue.
Physicians should not underestimate the magnitude of the problems arising from suicide and those experiencing it may benefit not only from psychiatric help but also from psychosocial interventions.
The latest Act for Lifes for use in clinical research was the Act for Lifes for Therapeutic Use, the Act for Therapeutic Use which was issued in 2016.
Suicide in the young is mostly due to [mood disorders, depression, and interpersonal conflicts at school]. The leading cause of suicide of people aged ≥30 years is unintentional overdosing of [acetaminophen (paracetamol-acetate mix), alcohol, and other prescription drugs]. If prescribed, [Paracetamol (acetaminophen) or Non-steroidal anti-inflammatory drugs (NSAIDS) should be reduced or discontinued immediately after [treatment of] an overdose of [acetaminophen-based products. If any of these three [toxicants] is prescribed to a suicide victim, the prescribing doctor should not be responsible for giving that order.
In a recent study, findings clearly shows that act is frequently used in combination with other treatments in Germany irrespective of psychiatric diagnosis and severity.
Data from a recent study suggest an inverse relationship between family size and the risk of suicide, and a similar effect for the number of children. Prospective studies, however, must be attempted to confirm these relationships and to identify the mechanisms.
While many young people find it helpful to find a mentor, most have a single main sponsor and find it challenging to manage their lives, balancing education and work. Young people with mentors tend to feel more supported and more in control of their studies, and more willing to get involved more in their own education and career. However people may find it difficult to find the mentors they want because of the social network that is needed for mentors to have.